These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23504457)

  • 21. Knockout mouse models for intestinal electrolyte transporters and regulatory PDZ adaptors: new insights into cystic fibrosis, secretory diarrhoea and fructose-induced hypertension.
    Seidler U; Singh A; Chen M; Cinar A; Bachmann O; Zheng W; Wang J; Yeruva S; Riederer B
    Exp Physiol; 2009 Feb; 94(2):175-9. PubMed ID: 18931049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.
    Yu W; Kim Chiaw P; Bear CE
    J Biol Chem; 2011 Jul; 286(28):24714-25. PubMed ID: 21602569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Uses its C-Terminus to Regulate the A2B Adenosine Receptor.
    Watson MJ; Lee SL; Marklew AJ; Gilmore RC; Gentzsch M; Sassano MF; Gray MA; Tarran R
    Sci Rep; 2016 Jun; 6():27390. PubMed ID: 27278076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of human cystic fibrosis transmembrane conductance regulator (CFTR) by serum- and glucocorticoid-inducible kinase (SGK1).
    Sato JD; Chapline MC; Thibodeau R; Frizzell RA; Stanton BA
    Cell Physiol Biochem; 2007; 20(1-4):91-8. PubMed ID: 17595519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator.
    Swiatecka-Urban A; Duhaime M; Coutermarsh B; Karlson KH; Collawn J; Milewski M; Cutting GR; Guggino WB; Langford G; Stanton BA
    J Biol Chem; 2002 Oct; 277(42):40099-105. PubMed ID: 12167629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct sensing of intracellular pH by the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel.
    Chen JH; Cai Z; Sheppard DN
    J Biol Chem; 2009 Dec; 284(51):35495-506. PubMed ID: 19837660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis.
    Holcomb J; Spellmon N; Trescott L; Sun F; Li C; Yang Z
    Curr Drug Targets; 2015; 16(9):945-50. PubMed ID: 25523900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    Chung WJ; Goeckeler-Fried JL; Havasi V; Chiang A; Rowe SM; Plyler ZE; Hong JS; Mazur M; Piazza GA; Keeton AB; White EL; Rasmussen L; Weissman AM; Denny RA; Brodsky JL; Sorscher EJ
    PLoS One; 2016; 11(10):e0163615. PubMed ID: 27732613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
    Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
    J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased diffusional mobility of CFTR at the plasma membrane after deletion of its C-terminal PDZ binding motif.
    Haggie PM; Stanton BA; Verkman AS
    J Biol Chem; 2004 Feb; 279(7):5494-500. PubMed ID: 14660592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the C terminus and Na+/H+ exchanger regulatory factor in the functional expression of cystic fibrosis transmembrane conductance regulator in nonpolarized cells and epithelia.
    Benharouga M; Sharma M; So J; Haardt M; Drzymala L; Popov M; Schwapach B; Grinstein S; Du K; Lukacs GL
    J Biol Chem; 2003 Jun; 278(24):22079-89. PubMed ID: 12651858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of Phosphorylation-dependent Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Disease-causing Mutations at the Transmission Interface.
    Chin S; Yang D; Miles AJ; Eckford PDW; Molinski S; Wallace BA; Bear CE
    J Biol Chem; 2017 Feb; 292(5):1988-1999. PubMed ID: 28003367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of the Chaperone-Like HspB5 Rescues Trafficking and Function of F508del-CFTR.
    Degrugillier F; Aissat A; Prulière-Escabasse V; Bizard L; Simonneau B; Decrouy X; Jiang C; Rotin D; Fanen P; Simon S
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LMTK2-mediated phosphorylation regulates CFTR endocytosis in human airway epithelial cells.
    Luz S; Cihil KM; Brautigan DL; Amaral MD; Farinha CM; Swiatecka-Urban A
    J Biol Chem; 2014 May; 289(21):15080-93. PubMed ID: 24727471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annexin V is directly involved in cystic fibrosis transmembrane conductance regulator's chloride channel function.
    Trouvé P; Le Drévo MA; Kerbiriou M; Friocourt G; Fichou Y; Gillet D; Férec C
    Biochim Biophys Acta; 2007 Oct; 1772(10):1121-33. PubMed ID: 17869070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis.
    Verkman AS; Lukacs GL; Galietta LJ
    Curr Pharm Des; 2006; 12(18):2235-47. PubMed ID: 16787252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of synergistic combinations of F508del cystic fibrosis transmembrane conductance regulator (CFTR) modulators.
    Lin S; Sui J; Cotard S; Fung B; Andersen J; Zhu P; El Messadi N; Lehar J; Lee M; Staunton J
    Assay Drug Dev Technol; 2010 Dec; 8(6):669-84. PubMed ID: 21050065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR: implications for cystic fibrosis.
    Wagner CA; Ott M; Klingel K; Beck S; Melzig J; Friedrich B; Wild KN; Bröer S; Moschen I; Albers A; Waldegger S; Tümmler B; Egan ME; Geibel JP; Kandolf R; Lang F
    Cell Physiol Biochem; 2001; 11(4):209-18. PubMed ID: 11509829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. F508del-CFTR increases intracellular Ca(2+) signaling that causes enhanced calcium-dependent Cl(-) conductance in cystic fibrosis.
    Martins JR; Kongsuphol P; Sammels E; Dahimène S; Aldehni F; Clarke LA; Schreiber R; de Smedt H; Amaral MD; Kunzelmann K
    Biochim Biophys Acta; 2011 Nov; 1812(11):1385-92. PubMed ID: 21907281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratin K18 increases cystic fibrosis transmembrane conductance regulator (CFTR) surface expression by binding to its C-terminal hydrophobic patch.
    Duan Y; Sun Y; Zhang F; Zhang WK; Wang D; Wang Y; Cao X; Hu W; Xie C; Cuppoletti J; Magin TM; Wang H; Wu Z; Li N; Huang P
    J Biol Chem; 2012 Nov; 287(48):40547-59. PubMed ID: 23045527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.